Gazyva 1000mg Solution for Infusion
By Gazyva
Rx
40ml Solution for Infusion in a Vial

Composition
Obinutuzumab(1000mg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
October, 2025

liver
Gazyva 1000mg Solution for Infusion is generally considered safe for use in patients with liver disease, and no specific dose adjustments are needed. However, it is important to monitor patients who are positive for hepatitis B virus (HBV) both during and after treatment. If there is any reactivation of HBV, it is advised to stop using Gazyva 1000mg Solution for Infusion. Be vigilant for any signs or symptoms of HBV reactivation and consult with your healthcare provider promptly if any concerns arise.

kidney
When using Gazyva 1000mg Solution for Infusion, caution is advised for patients with kidney disease. Dose adjustment may be necessary, so it's important to consult your doctor.

alcohol
Consult your doctor when consuming alcohol with Gazyva 1000mg Solution for Infusion.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Gazyva 1000mg Solution for Infusion.

pregnancy
Gazyva 1000mg Solution for Infusion may not be safe during pregnancy. Animal studies indicate potential harm to the baby. Your doctor will assess the risks versus benefits before prescribing. Consult your doctor for more information.

breastfeeding
Caution should be taken when breastfeeding while using Gazyva 1000mg Solution for Infusion as it may be unsafe. Limited data indicates that the drug could pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | Peptides |
Therapeutic Class | - |
Action Class | Monoclonal antibodies |
₹399305
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025